Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept

Nizar Al-Ani,1 Faiq Gorial,1 Dina Yasiry,2 Fadya Al Derwibee,2 Yasameen Abbas Humadi,3 Nancy Sunna,4 Ali AlJabban5 1Rheumatology Unit, College of Medicine, University of Baghdad, Baghdad, Iraq; 2Department of Rheumatology, Baghdad Teaching Hospital, Baghdad, Iraq; 3College of Medicine, Al-Nahrain Un...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Al-Ani N, Gorial F, Yasiry D, Al Derwibee F, Abbas Humadi Y, Sunna N, AlJabban A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	autoimmunity biologics delayed treatment of rheumatoid arthritis early treatment of rheumatoid arthritis real-world data tnf inhibitors Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/dc863b4ed8524af5a144a2552185031f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept

Ejemplares similares